Cargando…
Chemotherapy for primary mediastinal yolk sac tumor in a patient undergoing chronic hemodialysis: a case report
BACKGROUND: The safety and efficacy of chemotherapy for patients undergoing concomitant hemodialysis have not been fully established and optimal doses of anti-cancer drugs and best timing of hemodialysis remains unclear. Although chemosensitive cancers, such as germ cell tumors, treated with chemoth...
Autores principales: | Hirakawa, Haruki, Nakashima, Chiho, Nakamura, Tomomi, Masuda, Masanori, Funakoshi, Taro, Nakagawa, Shunsaku, Horimatsu, Takahiro, Matsubara, Kazuo, Muto, Manabu, Kimura, Shinya, Sueoka-Aragane, Naoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312436/ https://www.ncbi.nlm.nih.gov/pubmed/28202048 http://dx.doi.org/10.1186/s13256-017-1213-7 |
Ejemplares similares
-
Paraneoplastic Limbic Encephalitis Complicated with Small Cell Lung Cancer at the Time of Recurrence
por: Sadamatsu, Hironori, et al.
Publicado: (2019) -
A rare case of brain metastatic of primary mediastinal yolk sac tumor
por: Cecilia, Cindy, et al.
Publicado: (2023) -
Primary mediastinal yolk sac tumor: A case report and literature review
por: Wu, Diqing, et al.
Publicado: (2023) -
ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies
por: Matsumoto, Akiko, et al.
Publicado: (2021) -
A primary mediastinal germ cell tumor of yolk sac type: case report
por: Darif, Khadija, et al.
Publicado: (2021)